🇺🇸 FDA

Intelligence · Clinical Pipeline

Approved programs Pipeline Programs

ClinicalTrials.gov programs marked approved or launched in registry data.

Programs
1,839

Quick answer

NovaPharmaNews tracks 1,839 approved programs pharmaceutical pipeline programs from ClinicalTrials.gov. ClinicalTrials.gov programs marked approved or launched in registry data.

Top sponsors

Page 22 of 39

  1. Nocardia rubra Cell Wall Skeleton

    The First People's Hospital of Lianyungang

    Diabetic Foot Ulcer

    approved small molecule active

    1 trial

  2. Norepinephrine

    Xiyuan Hospital of China Academy of Chinese Medical Sciences

    Septic Shock

    approved small molecule completed

    1 trial

  3. Norfloxacino Sandoz 400 mg comprimidos EFG

    The George Institute

    Hospitalized patients with decompensated cirrhosis, diagnosed with bacterial infection evolution lasting for 48 hours or less.

    approved small molecule active

    1 trial

  4. Normal Saline

    Nanjing Zenshine Pharmaceuticals

    Breast Feeding

    approved small molecule completed

    1 trial

  5. Normal saline

    Xiyuan Hospital of China Academy of Chinese Medical Sciences

    STEMI - ST Elevation Myocardial Infarction

    approved small molecule active

    1 trial

  6. Nucala 100 mg solution for injection in pre-filled pen, Nucala 100 mg solution for injection in pre-filled syringe, Nucala 100 mg solution for injection in pre-filled syringe, Nucala 100 mg solution for injection in pre-filled pen, Nucala 100 mg solution for injection in pre-filled pen, Nucala 100 mg solution for injection in pre-filled syringe

    GlaxoSmithKline

    severe asthma

    approved small molecule active

    1 trial

  7. OMACOR

    United Therapeutics Europe Ltd

    Non-Alcoholic Fatty Liver Disease

    approved small molecule completed

    1 trial

  8. ONTAK (denileukin difitox, DAB389IL-2)

    LIGAND PHARMACEUTICALS INC

    Lymphoma, T-Cell, Cutaneous

    approved small molecule completed

    1 trial

  9. OOPEN+BBCC

    BRIGHT MINDS BIOSCIENCES INC.

    Opioid Overdose

    approved small molecule completed

    1 trial

  10. OPDIVO 10 mg/mL concentrate for solution for infusion., CABOMETYX 20 mg film-coated tablets, CABOMETYX 40 mg film-coated tablets

    The George Institute

    Renal carcinoma

    approved small molecule active

    1 trial

  11. ORENCIA 125 mg solution for injection in pre-filled syringe, ORENCIA 125 mg solution for injection in pre-filled syringe, RoActemra 162 mg solution for injection in pre-filled syringe., ORENCIA 125 mg solution for injection in pre-filled syringe, ORENCIA 125 mg solution for injection in pre-filled syringe, RoActemra 162 mg solution for injection in pre-filled syringe., ORENCIA 125 mg solution for injection in pre-filled syringe, ORENCIA 125 mg solution for injection in pre-filled syringe, ORENCIA 125 mg sol

    The George Institute

    Adults patients suffering from rheumatoid arthritis and in adequate response to one or two targeted treatments.

    approved small molecule active

    1 trial

  12. OROS hydromorphone

    Janssen Cilag International NV

    Cancer Pain

    approved small molecule completed

    1 trial

  13. OXALIPLATIN, CAPECITABINE

    Disc Medicine

    Locally advanced or metastatic gastro-intestinal carcinoma

    approved small molecule active

    1 trial

  14. Ocrevus 300 mg concentrate for solution for infusion

    Hoffmann-La Roche

    Multiple Sclerosis (MS) or Clinically Isolated Syndrome (CIS) [in line with the locally approved indications]

    approved small molecule active

    1 trial

  15. Octocog alfa (recombinant human coagulation factor VIII) [ADVATE]

    Takeda

    Hemophilia A

    approved mab completed

    2 trials

  16. Ofatumumab

    Novartis Pharmaceuticals

    Relapsing Multiple Sclerosis

    approved mab completed

    1 trial

  17. Offer of voucher for cost-free Nicotine Replacement Therapy

    United Therapeutics Europe Ltd

    Tobacco Smoking

    approved small molecule completed

    1 trial

  18. Ofirmev

    CUMBERLAND PHARMACEUTICALS INC

    Pain

    approved small molecule completed

    1 trial

  19. Olanzapine

    United Therapeutics Europe Ltd

    Acute Agitation, Behavioural Emergency

    approved small molecule terminated

    1 trial

  20. Olutasidenib

    RIGEL PHARMACEUTICALS INC

    AML (Acute Myeloid Leukemia)

    approved small molecule active

    1 trial

  21. Omega 3-Atorvastatin

    United Therapeutics Europe Ltd

    Dyslipidemias

    approved small molecule active

    1 trial

  22. Omvoh 100 mg solution for injection in pre-filled syringe, Omvoh 100 mg + 200 mg solution for injection in pre-filled syringe, Omvoh 100 mg solution for injection in pre-filled pen, Omvoh 100 mg solution for injection in pre-filled pen, Omvoh 100 mg + 200 mg solution for injection in pre-filled syringe, Omvoh 100 mg solution for injection in pre-filled syringe, Omvoh 100 mg solution for injection in pre-filled pen, Omvoh 100 mg + 200 mg solution for injection in pre-filled pen, Omvoh 100 mg + 200 mg solutio

    Eli Lilly Co.

    severely active ulcerative colitis (US) and CD (Crohn’s disease)

    approved small molecule active

    1 trial

  23. Optimal hypoglycemic treatment

    The First People's Hospital of Lianyungang

    Type2 Diabetes

    approved other active

    1 trial

  24. Oral Methamphetamine

    BRIGHT MINDS BIOSCIENCES INC.

    HIV-1-infection

    approved small molecule completed

    1 trial

  25. Oral Zonisamide Therapy

    Affiliated Hospital of Nantong University

    Epilepsies, Partial

    approved small molecule active

    1 trial

  26. Oral consumption

    BRIGHT MINDS BIOSCIENCES INC.

    Growth Acceleration

    approved other completed

    1 trial

  27. Oral hygiene intervention

    The University of Hong Kong

    Acute Stroke

    approved other completed

    1 trial

  28. Oral prednisolone (30mg/day) for 28 days

    Hospital Authority, Hong Kong

    Esophageal Neoplasms

    approved small molecule active

    1 trial

  29. Ornithine aspartate granule

    The First People's Hospital of Lianyungang

    Non-alcoholic Fatty Liver Disease

    approved small molecule completed

    1 trial

  30. Osilodrostat (Isturisa)

    Ultragenyx UK Limited

    Mild Autonomous Cortisol Secretion (MACS)

    approved small molecule active

    1 trial

  31. Oxycodone

    Hospital Authority, Hong Kong

    Postcraniotomy Pain

    approved small molecule completed

    1 trial

  32. Oxycodone

    BRIGHT MINDS BIOSCIENCES INC.

    Chronic Low Back Pain

    approved small molecule completed

    1 trial

  33. Oxycodone Hydrochloride

    Xiyuan Hospital of China Academy of Chinese Medical Sciences

    Analgesia, Patient-Controlled

    approved small molecule active

    1 trial

  34. Oxymetazoline HCL 1.0% Cream

    Aclaris Therapeutics

    Rosacea

    approved small molecule completed

    1 trial

  35. Ozempic 1 mg solution for injection in pre-filled pen, Dapagliflozin 10 mg film-coated tablets

    The George Institute

    Type 2 diabetes

    approved small molecule active

    1 trial

  36. Ozempic 1 mg solution for injection in pre-filled pen, Ozempic 0.5 mg solution for injection in pre-filled pen, Ozempic 2 mg solution for injection in pre-filled pen, Ozempic 0.25 mg solution for injection in pre-filled pen

    Disc Medicine

    Diabetic foot ulcer

    approved small molecule active

    1 trial

  37. PALEXIA Retard 50 mg tabletten met verlengde afgifte

    Disc Medicine

    chronic postoperative pain

    approved small molecule active

    1 trial

  38. PCIA group

    The First People's Hospital of Lianyungang

    Postoperative Pain

    approved other active

    1 trial

  39. PDD regimen: doxorubicin hydrochloride iposome, bortizomib and dexamethasone

    The First People's Hospital of Lianyungang

    Multiple Myeloma

    approved small molecule active

    1 trial

  40. PEG-IFN alfa-2a

    Hoffmann-La Roche

    Hepatitis C, Chronic

    approved small molecule completed

    1 trial

  41. PEG-rhG-CSF

    Xiyuan Hospital of China Academy of Chinese Medical Sciences

    Cervical Cancer

    approved small molecule active

    1 trial

  42. PEG-somatropin

    Xiyuan Hospital of China Academy of Chinese Medical Sciences

    Growth Hormone Deficiency

    approved mab active

    2 trials

  43. PEG-somatropin

    The First People's Hospital of Lianyungang

    Growth Hormone Deficiency

    approved mab active

    1 trial

  44. PEG-somatropin

    Changchun GeneScience Pharmaceutical Co.,

    Growth Hormone Deficiency

    approved mab active

    1 trial

  45. PEMBROLIZUMAB , NIVOLUMAB , IPILIMUMAB

    Disc Medicine

    Melanoma

    approved small molecule active

    1 trial

  46. PERSERIS

    Indivior Pty Ltd

    Schizophrenia

    approved small molecule completed

    1 trial

  47. PL-ASA

    Protalix BioTherapeutics

    Healthy Volunteers

    approved small molecule completed

    1 trial

  48. PLACEBO, ISMIGEN tabletki podjezykowe

    Lacuna Pharma Pty Ltd

    Respiratory Tract Infections

    approved small molecule active

    1 trial

Frequently asked questions

How many Approved programs pipeline programs are in the directory?

1,839 published programs match this development stage in our ClinicalTrials.gov index.

What defines this pipeline stage?

Phase and status reflect ClinicalTrials.gov registry fields at last sync. See our clinical trial phases reference for methodology.

Data attribution: Data sources · All pipeline programs

Drug approvals, clinical trials, M&A, event intelligence, and company updates — weekly.

Customize topics & region
Topics
Region

No spam. Unsubscribe anytime. See our privacy policy.